Skip to main content
Premium Trial:

Request an Annual Quote

Polyplus-transfection Licenses ZNA Oligonucleotides to Metabion

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Polyplus-transfection, a Strasbourg, France-based molecular and cell biology tools company, has inked a licensing deal covering zip nucleic acid (ZNA) oligonucleotides with German firm Metabion.

Under the terms of the agreement, Metabion has been granted a non-exclusive license to manufacture and commercialize Polyplus-transfection's ZNA oligonucleotides, a new technology that increases the affinity for nucleic acids without reducing specificity, the French firm said. Metabion, which is a custom nucleic acids supplier, has the right to sell the ZNA oligos for research and in vitro diagnostic applications, beginning March 22.

According to Polyplus-transfection, the ZNAs improve the performance of molecular hybridization techniques, such as PCR assays when used as primers or probes. The technology also increases the sensitivity of tests and the detection of mutations, the firm said.

Financial and other terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.